Estimate Recalculated Sep 12, 2024 10:14PM EST
Mark Rothera has an estimated net worth of $4.78 Million. This is based on reported shares across multiple companies, which include PTC THERAPEUTICS, INC., Orchard Therapeutics plc, Viracta Therapeutics, Inc., and Aegerion Pharmaceuticals, Inc..
Mark Rothera's CIK is 0001550424
2015 was Mark Rothera's most active year for acquiring shares with 15 total transactions. Mark Rothera's most active month to acquire stocks was the month of December. 2015 was Mark Rothera's most active year for disposing of shares, totalling 21 transactions. Mark Rothera's most active month to dispose stocks was the month of August. 2015 saw Mark Rothera paying a total of $4,211,243.60 for 139,766 shares, this is the most they've acquired in one year. In 2015 Mark Rothera cashed out on 113,216 shares for a total of $4,101,356.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!